All News

The French presidential election is unlike any previous one: this time, both right and left are hoisting research policy to the top of their agendas.

In a rare example of a university tec transfer deal attracting an upfront payment, French pharma company Ipsen paying €1.25 million for a treatment licence.

The UK government has given £1.1 million to Plasticell Ltd to fund the development of a system to automate stem cell research.

Europe has staked its future on building a knowledge economy. But once again, a major R&D investment by one of its leading companies is going to the US.

Scotland is investing £9.5 million of public money in the Swedish stem cell company Cellartis AB to fund an R&D and manufacturing facility in Dundee.

Global acceptance of biotech crops increased in 2006, with acreage reaching 102 million hectares in 22 countries, according to a new report.